RT Journal Article
SR Electronic
T1 SARS-CoV-2 infection and transmission in school settings during the second wave in Berlin, Germany: a cross-sectional study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.27.21250517
DO 10.1101/2021.01.27.21250517
A1 Theuring, Stefanie
A1 Thielecke, Marlene
A1 van Loon, Welmoed
A1 Hommes, Franziska
A1 Hülso, Claudia
A1 von der Haar, Annkathrin
A1 Körner, Jennifer
A1 Schmidt, Michael
A1 Böhringer, Falko
A1 Mall, Marcus A.
A1 Rosen, Alexander
A1 von Kalle, Christof
A1 Kirchberger, Valerie
A1 Kurth, Tobias
A1 Seybold, Joachim
A1 Mockenhaupt, Frank P.
A1 ,
YR 2021
UL http://medrxiv.org/content/early/2021/01/29/2021.01.27.21250517.abstract
AB Background School attendance during the SARS-CoV-2 pandemic is intensely debated. Modelling studies suggest that school closures contribute to community transmission reduction. However, data among school-attending students and staff are scarce. In November 2020, we examined SARS-CoV-2 infections and seroreactivity in 24 randomly selected school classes and connected households in Berlin, Germany.Methods Students and school staff were examined, oro-nasopharyngeal swabs and blood samples collected, and SARS-CoV-2 infection and IgG antibodies detected by RT-PCR and ELISA. Household members performed self-swabs. Individual and institutional infection prevention and control measures were assessed. Classes with SARS-CoV-2 infection and connected household members were re-tested after one week.Findings 1119 participants were examined, including 177 primary and 175 secondary school students, 142 staff, and 625 household members. Participants reported mainly cold symptoms (19·4%). SARS-CoV-2 infection occurred in eight of 24 classes affecting each 1-2 individuals. Infection prevalence was 2·7% (95%CI; 1·2-5·0%; 9/338), 1·4% (0·2-5·1%; 2/140), and 2·3% (1·3-3·8%; 14/611) among students, staff and household members, respectively, including quarantined persons. Six of nine infected students were asymptomatic. Prevalence increased with inconsistent facemask use in school, way to school on foot, and case-contacts outside school. IgG antibodies were detected in 2·0% (0·8-4·1%; 7/347), 1·4% (0·2-5·0%; 2/141) and 1·4% (0·6-2·7%; 8/576), respectively. For three of nine households with infection(s) detected at cross-sectional assessment, origin in school seemed possible. After one week, no school-related, secondary infections appeared in affected classes; the attack rate in connected households was 1·1%.Interpretation These data suggest that school attendance under preventive measures is feasible, provided their rigorous implementation. In balancing threats and benefits of open versus closed schools during the pandemic, parents and society need to consider possible spill-overs into their households. Deeper insight is needed into the infection risks due to being a schoolchild as compared to attending school.Funding Senate of Berlin.Competing Interest StatementTK states to have received outside of the submitted work personal fees from Eli Lily, Newsenselab, Total and BMJ. All other authors declare they have no conflict of interests.Funding StatementThis work was funded by the Senate of Berlin. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was reviewed by the Ethics Committee of Charite - Universitaetsmedizin Berlin (EA2/091/20). Informed written consent and assent was obtained from all participants and legal representatives.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDe-identified participant data and data dictionary will be available for academic institutions upon request and following approval of an analysis proposal through the Institute of Tropical Medicine and International Health, Charite - Universitaetsmedizin Berlin, for 12 months after publication of results.